Literature DB >> 6192498

Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

J Folkman, R Langer, R J Linhardt, C Haudenschild, S Taylor.   

Abstract

Heparin or a heparin fragment administered with cortisone inhibited angiogenesis, caused regression of large tumor masses, and prevented metastases. Oral administration of heparin resulted in the release of non-anticoagulant heparin fragments in the serum which, in the presence of cortisone, had similar anti-angiogenic and antitumor effects. Of all the heparin fragments tested, the most potent inhibition of angiogenesis in the presence of cortisone was provided by a hexasaccharide with a molecular weight of about 1600.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192498     DOI: 10.1126/science.6192498

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  111 in total

1.  Specific plate assay for bacterial heparinase.

Authors:  J J Zimmermann; R Langer; C L Cooney
Journal:  Appl Environ Microbiol       Date:  1990-11       Impact factor: 4.792

2.  Effects of the oral administration of glycosaminoglycans on cellular abnormalities associated with idiopathic calcium oxalate nephrolithiasis.

Authors:  B Baggio; G Gambaro; G Marzaro; F Marchini; A Borsatti; G Crepaldi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Polysaccharides as antiviral agents: antiviral activity of carrageenan.

Authors:  M E González; B Alarcón; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

4.  Tumour angiogenesis.

Authors:  J S Gelister; M R Lewin; P B Boulos
Journal:  Ann R Coll Surg Engl       Date:  1986-05       Impact factor: 1.891

5.  Isolation, characterization, and localization of heparin-binding growth factors in the heart.

Authors:  W Casscells; E Speir; J Sasse; M Klagsbrun; P Allen; M Lee; B Calvo; M Chiba; L Haggroth; J Folkman
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 6.  Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms.

Authors:  Ning Zhang; Weihua Lou; Fang Ji; Lihua Qiu; Benjamin K Tsang; Wen Di
Journal:  J Cancer Res Clin Oncol       Date:  2016-02-24       Impact factor: 4.553

Review 7.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 8.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

9.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  The use of angiostatic steroids to inhibit cartilage destruction in an in vivo model of granuloma-mediated cartilage degradation.

Authors:  P R Colville-Nash; M el-Ghazaly; D A Willoughby
Journal:  Agents Actions       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.